1. Academic Validation
  2. [Chloroxoquinoline inhibits invasion in breast cancer via down-regulating Rho/Rho kinase signaling pathway]

[Chloroxoquinoline inhibits invasion in breast cancer via down-regulating Rho/Rho kinase signaling pathway]

  • Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 Dec 25;48(6):631-637. doi: 10.3785/j.issn.1008-9292.2019.12.07.
Jingwen Liu 1 Xinglian Yang 1 Kaili Shen 1 Linghui Zeng 1 Yan Sun 2
Affiliations

Affiliations

  • 1 School of Medicine, Zhejiang University City College, Hangzhou 310015, China.
  • 2 Department of Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China.
Abstract

Objective: To investigate the effect of chloroxoquinoline on Cytoskeleton of breast Cancer cells and its relation with Rho/Rho kinase signaling pathway.

Methods: Breast Cancer Bcap37 and MDA-MB-453 cells were treated with different concentrations of chloroxoquinoline. Wound healing and Transwell assay were conducted to detect cell migration and invasion, respectively. Rhodamine-phalloidin staining and immunofluorescent staining were used to observe the polymerization state of F-actin and the expression of α-Tublin in breast Cancer cells, respectively. Western blot was used to detect the phosphorylation level of key protein in Rho/Rho kinase signaling pathway.

Results: Compared with the control group, chloroxoquinoline treatment induced dose-dependent decrease in cell migration and invasion, and Bcap37 and MDA-MB-453 cells treated with chloroxoquinoline showed dose-dependent changes in cell morphology and decrease in cell body. The staining of F-actin and α-Tublin was irregular and clustered. Furthermore, treatment of chloroxoquinoline down-regulated the phosphorylation of the Rho/Rho kinase signaling proteins Cofilin, Limk and ROCK2 (all P<0.01).

Conclusions: Chloroxoquinoline inhibits the Cytoskeleton in breast Cancer Bcap37 and MDA-MB-453 cells and inhibits cell migration. This effect may be associated with down-regulation of Rho/Rho kinase signaling pathway.

Figures
Products